Responses
Regular and young investigator award abstracts
Checkpoint blockade therapy
241 Clinical outcomes of metastatic melanoma patients with liver metastases treated with anti-PD-1 monotherapy versus combination ipilimumab/nivolumab
Compose a Response to This Article
Other responses
No responses have been published for this article.